Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-12-02 | Amended | $21,176,893 | $2,265,952 | Equity Only | 06b | SEC link |
| 2022-06-08 | New | $18,910,941 | $18,910,941 | Equity Only | 06b | SEC link |
| 2021-03-29 | Amended | $5,500,000 | $500,000 | Debt Only | 06b | SEC link |
| 2021-03-26 | New | $5,000,000 | $5,000,000 | Debt Only | 06b | SEC link |
| 2019-06-28 | New | $1,854,978 | $1,854,978 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Ritish Agarwal | Director |
| James Laur | Director |
| Oded Levy | Director |
| Matthew Mitcho | Director, Executive |
| John A. Neczesny | Director |
| Mark Pimentel | Director, Executive |